Best Overall
AncestryDNA
Largest consumer matching pool by a wide margin.
Tree, record and ThruLines tools turn matches into research.
No health reports, and no uploads from other services.
6 Best DNA Test Kit
ReviewTier EditorialAdvertising Disclosure
Updated At Oct 6, 2026
MyHeritage DNA
Cheapest of the major three at list price.
Strong reference coverage for European populations.
The only major kit that accepts free uploads from rivals.
Hot Deal
23andMe Health + Ancestry
The only mainstream kit with FDA-authorized health reports.
Chromosome browser and haplogroup detail included.
Bankruptcy and a 2023 breach weigh on the governance score.
FamilyTreeDNA
Y-DNA and mtDNA testing for deep paternal and maternal lines.
Best tooling for serious genealogists.
Smallest pool and the steepest learning curve here.
Living DNA
Fine-grained regional breakdowns, especially within Britain and Ireland.
Lower price point than the US majors.
Smaller database limits relative matching.
Sequencing.com
Whole-genome sequencing rather than a genotyping array.
App marketplace for third-party analysis.
The most data for the most work, and the least hand-holding.
You might also like
What a DNA kit actually sells you
Strip away the ethnicity pie chart and a consumer DNA kit is three things sold together: a one-time sequencing run, an account in a matching database, and a set of terms governing how your genetic data gets used, shared, and retained. The sequencing is commoditized. The database is a network effect you cannot replicate on your own. The terms are the part with the longest tail.
That is why two kits at very different prices can return similar-looking percentages and still be very different purchases. The percentages are an estimate produced by comparing your markers against a reference panel; the panel and the algorithm behind it vary by company, which is why the same person can appear 62% one thing at one service and 58% at another without either being fraudulent.
AncestryDNA's advantage is scale. A pool in the tens of millions means more chances of a usable match, and the integration with historical records turns a match into a name and a place. What it does not sell is health reporting, and it does not accept raw uploads from other services.
23andMe's advantage is regulatory. Its health reports carry FDA authorization, which no other mainstream consumer kit can claim. The offset is corporate: a 2025 bankruptcy, an asset sale, and a 2023 breach affecting millions of accounts. That does not make the reports invalid, but it does change the calculus for anyone whose main concern is who holds the data in five years.
MyHeritage's advantage is price and flexibility. It is the cheapest of the three at list, it is strong on European reference populations, and it accepts free uploads, which makes it the natural second database rather than a replacement for a first one.
We do not run our own sequencing, and we do not tell you what a result means for your health. The scores below measure verifiable properties: laboratory accreditation, whether claims are backed by an authorization or a certification that can be looked up, how clearly consent and research participation are separated, and what the retention and deletion policy actually commits to. A high score means better documentation and governance. It does not mean the kit is more accurate, and it does not mean a health result is something to act on without a clinician.
Integrity
The scores below compare these kits against the same health, evidence, and governance topics. A high score means stronger documentation or verification within that topic. It does not mean the product is risk-free, and it does not mean a health report should be read without professional context.
HHealth & Safety
Health report scope and clinical limits
This measures whether a health report states which conditions are covered, whether that coverage rests on an authorization that can be verified, and whether the product is explicit that a result is risk information rather than a diagnosis. It matters because 'health DNA test' is used loosely in marketing while the regulated scope is narrow and specific.
Access to genetic counseling
This measures whether a customer who receives a concerning result has a route to a qualified human, whether that route is included or sold separately, and whether the company tells you to seek one. It matters because a raw probability without interpretation is where consumer genomics most often goes wrong.
Sample collection and consent clarity
This measures whether consent for testing and consent for research are separate choices, whether the default is opt-in or opt-out, and how clearly the sample-destruction option is presented. It matters because bundled consent is the quiet mechanism by which genetic data enters research programs.
EEvidence
Lab accreditation and validation
This measures whether the laboratory behind the kit holds accreditation that can be independently checked, and whether the company names it. It matters because the consumer sees a dashboard, not a lab, and accreditation is the main external signal that the pipeline is what it claims to be.
Verifiability of marketing claims
This measures whether headline claims map to something a customer can look up: an authorization, a certification, a published methodology. It matters because consumer genomics marketing routinely implies clinical certainty that no authorization supports.
Database size and match quality
This measures the size of the matching pool and how usable a match is once found, including tree tools and record integration. It matters because relative matching is a network problem, and a better algorithm on a small pool loses to a plain algorithm on a large one.
Ethnicity methodology transparency
This measures whether the company explains its reference panels, states that estimates are estimates, and publishes how regions are defined. It matters because the same DNA can produce different regional percentages at different services without any of them being wrong.
EEcology
Data retention and deletion
This measures what the policy commits to on retention, whether account deletion also destroys the physical sample, and whether backups are addressed. It matters because genetic data is uniquely persistent: a leaked password can be changed, a sequenced genome cannot.
Corporate stability and ownership
This measures ownership history, financial distress, and whether customers were told what happens to their data in a change of control. It matters because the 2025 bankruptcy showed that a data custodian can change without the customer doing anything at all.
Research use and third-party sharing
This measures whether research participation is opt-in, whether third-party sharing is described specifically rather than gestured at, and whether law-enforcement requests are addressed in the policy. It matters because these are the clauses customers most often assume rather than read.
Full reviews
#1 - Best Overall
AncestryDNA
Buyer Score 92/100Integrity Score 73/100Ancestry
Overview
AncestryDNA wins on the one thing that compounds: other people. A matching pool in the tens of millions means more chances that a match is close enough to be useful, and the surrounding genealogy tools are what let a customer do something with a fourth cousin once the match appears. It sells no health reports, and it does not accept raw uploads from competitors, which makes it a first purchase rather than a hub.
What works
- Largest matching database in consumer testing
- Mature tree and historical record integration
- Regional ethnicity breakdowns at a fine grain
- Corporate ownership has been stable
What does not
- No health or trait reporting at all
- Does not accept raw data uploaded from other services
- Historical record access requires a separate subscription
- Ethnicity estimates for recent immigrant ancestry are less precise than the headline regions suggest
Who is it for
Anyone whose primary goal is finding living relatives or breaking through a genealogical wall.
Who is it not for
Anyone buying specifically for health risk information, or anyone who already tested elsewhere and wants to consolidate into one account.
Integrity
The absence of health reporting is a limitation, not a failure: with no clinical claims to defend, the product carries less interpretive risk. On governance, the company's ownership has been stable and its deletion process is documented, though deletion is a request rather than a one-click control and the physical sample needs a separate instruction.
#2 - Hot Deal
MyHeritage DNA
Buyer Score 87/100Integrity Score 69/100MyHeritage
Overview
MyHeritage is the pragmatic second database. It costs least of the big three, its reference panels are strong for European populations in particular, and it accepts free raw-data uploads, which means a customer who already tested with Ancestry can extend their match pool without paying for a second kit. The matching pool is materially smaller than Ancestry's, so it works better as an addition than as a starting point for someone chasing a close relative.
What works
- Lowest list price of the major three
- Free uploads from other services, unlike its rivals
- Best-in-class coverage for European and Jewish ancestry
- Chromosome browser included
What does not
- Smaller US matching pool than Ancestry
- Health and wellness add-ons lack FDA authorization
- Interface and support quality vary by region
- Uploaded data does not unlock the full feature set
Who is it for
European family trees, budget-first buyers, and anyone who already tested elsewhere and wants a free second pool.
Who is it not for
Someone whose only goal is finding a close US relative, where pool size matters more than price.
Integrity
Health add-ons exist but sit outside the FDA-authorized category, so treat them as wellness content rather than clinical reporting. Governance is unremarkable in a good way: documented deletion, no ownership disruption, and a policy that addresses research participation separately from testing consent.
#3
23andMe Health + Ancestry
Buyer Score 81/100Integrity Score 73/10023andMe
Overview
23andMe is the only mainstream consumer kit whose health reports carry FDA authorization, and that distinction is real rather than semantic: it means named reports were reviewed against a regulatory standard instead of self-certified. The ancestry side is competent, with a chromosome browser and haplogroup detail its rivals lack. The problem is everything around the test. The company filed Chapter 11 in March 2025 and its assets were sold under court supervision, and a 2023 breach exposed data tied to roughly 6.9 million accounts. That history belongs in the buying decision, not in a footnote.
What works
- FDA-authorized health reports, unique among mainstream kits
- Chromosome browser and Y/mtDNA haplogroup detail
- Clean separation of ancestry and health views
- Healthy report catalog with clear coverage labels
What does not
- Highest price of the three once health is included
- 2025 bankruptcy and change of ownership
- 2023 breach affecting millions of accounts
- Smaller matching pool than Ancestry, shrinking rather than growing
Who is it for
Buyers whose specific goal is FDA-authorized health and trait reporting, and who have read the current privacy terms rather than the pre-2025 version.
Who is it not for
Anyone buying primarily to find relatives, or anyone who is not comfortable with a data custodian that has already been through a change of control.
Integrity
The health reporting is the strongest in the category and the only part resting on an authorization. The governance picture is the weakest of the three: ownership changed under bankruptcy, the breach is documented, and research participation has historically been presented in a way that rewarded reading carefully. If you buy, download your raw data immediately and review whether you want the account to persist.
#4
FamilyTreeDNA
Buyer Score 78/100Integrity Score 62/100FamilyTreeDNA
Overview
FamilyTreeDNA does something the big three largely do not: dedicated Y-DNA and mitochondrial tests for tracing a single paternal or maternal line rather than estimating overall ancestry. For surname projects and deep lineage work that is genuinely useful, and the tools assume a user who knows what a haplogroup is. The trade-off is a much smaller autosomal pool, so it is a specialist instrument rather than a first kit for most people.
What works
- Real Y-DNA and mtDNA products, not just haplogroup labels
- Strong tooling for surname and lineage projects
- Established presence in the genealogy community
What does not
- Smallest matching pool of the kits compared here
- Assumes prior genealogy knowledge
- No health reporting
- Not a good first purchase for a casual buyer
Who is it for
Genealogists working a specific paternal or maternal line, or running a surname project.
Who is it not for
First-time buyers, or anyone hoping for health insight.
Integrity
No health claims, so no interpretive risk. Governance is conventional and the company has been stable, though the policy is written for a genealogy audience and is denser than the consumer-facing kits.
#5
Living DNA
Buyer Score 74/100Integrity Score 62/100Living DNA
Overview
Living DNA's pitch is granularity inside the British Isles, where the big three tend to collapse several distinct regions into one label. For someone whose family is English, Scottish, Welsh or Irish and who wants more texture than 'Britain and Ireland', that specificity is the product. Relative matching is a secondary feature here, and the database is small enough that it should not be the reason to buy.
What works
- Unusually fine regional resolution within Britain and Ireland
- Clear methodology write-up for a smaller vendor
- Lower entry price than the US majors
What does not
- Small database makes relative matching weak
- Limited health offering
- Smaller vendor with less corporate history to assess
Who is it for
Buyers with British or Irish ancestry who care about regional detail more than match volume.
Who is it not for
Anyone buying to find relatives, or anyone whose ancestry is primarily outside the British Isles.
Integrity
Health content is limited and should not be the reason to choose this kit. The methodology documentation is better than its size would suggest, and the deletion policy is straightforward.
#6
Sequencing.com
Buyer Score 70/100Integrity Score 59/100Sequencing.com
Overview
Sequencing.com sells whole-genome sequencing instead of the genotyping array the consumer kits use, then routes the resulting data through a marketplace of third-party apps. That is more raw information than any of the other kits provide, and it is also more rope: the apps vary in quality and in what they claim, and the company that sequenced your sample is not the company interpreting it. It became the practical whole-genome option after Nebula Genomics shut down in early 2025.
What works
- Whole-genome data rather than a fixed array
- Data is portable and reusable across analyses
- Fills a gap left by Nebula's closure
What does not
- Third-party app quality is uneven and inconsistent
- Weak relative matching
- Requires more user sophistication than any other kit here
- Interpretation responsibility sits with the customer
Who is it for
Users who want the underlying data and are comfortable evaluating analyses themselves.
Who is it not for
Anyone who wants a finished, interpreted answer, or who is buying mainly to find relatives.
Integrity
The health angle depends entirely on which third-party app you run, and those apps are not uniformly regulated, which is the central risk. On governance, portable data is a genuine advantage: you hold the file, so a change of vendor does not strand your results.